Sign in to continue:

Tuesday, March 24th, 2026

Assured Guaranty Re Ltd. 2025-2024 Financial Results and Portfolio Overview




Assured Guaranty Re Ltd. 2025 Financial Results: Key Highlights for Investors

Assured Guaranty Re Ltd. Reports Strong 2025 Financial Results

Key Points for Investors

  • Net Income Surges: Assured Guaranty Re Ltd. (“AG Re”), a wholly-owned subsidiary of Assured Guaranty Ltd., reported a net income of \$124.6 million for the year ended December 31, 2025, a substantial year-on-year increase from \$98.5 million in 2024.
  • Comprehensive Income Rises: Total comprehensive income for 2025 was \$162.5 million, up from \$88.4 million in 2024, reflecting strong operational performance and favorable investment results.
  • Dividend Payments: AG Re continued its practice of returning capital to shareholders, paying out \$80 million in dividends in 2025 versus \$97.4 million in 2024. This demonstrates ongoing commitment to shareholder value.
  • Shareholder Equity Strengthened: Shareholder’s equity increased to \$1.09 billion at year-end 2025, up from \$1.01 billion in 2024, driven by retained earnings and positive other comprehensive income.
  • Investment Portfolio: AG Re reported total investments of \$1.26 billion at fair value at December 31, 2025, including \$1.15 billion in fixed-maturity securities and \$142.5 million in short-term investments.
  • Operating Cash Flow: Net cash flows provided by operating activities were robust at \$79.3 million for 2025, supporting liquidity and financial flexibility.
  • Strong Asset Base: Total assets stood at \$2.24 billion as of December 31, 2025, compared to \$2.19 billion in 2024.
  • Credit Quality and Portfolio Mix: AG Re’s financial guaranty portfolio remains heavily weighted towards public finance (95.8% of net par outstanding in 2025), with a modest allocation to structured finance (5.8%). The portfolio’s internal ratings are strong, with the majority rated investment grade.
  • No Preferred Stock Outstanding: The company has no preferred shares issued, focusing shareholder returns via common equity and dividends.
  • Audit Opinion: The consolidated financial statements received an unqualified opinion from PricewaterhouseCoopers LLP, with no going concern issues identified, reinforcing confidence in the company’s financial reporting.

Details and Analysis

Financial Performance: AG Re delivered a robust financial performance in 2025, highlighted by a notable rise in net income and comprehensive income. The increase in net income was driven by higher net investment income (\$55.3 million vs. \$54.0 million in 2024), favorable fair value gains on credit derivatives (\$17.8 million vs. \$6.8 million), and higher other income (\$14.6 million vs. \$12.0 million). While there was a net realized investment loss of \$(1.7) million, this was offset by gains in other areas.

Investment Portfolio: The bulk of AG Re’s investments are in fixed-maturity securities, which provide stable cash flows and income. The company also maintains a smaller allocation to short-term investments and equity method investments. The investment portfolio appears well-diversified and conservative, in line with the company’s risk profile as a financial guaranty insurer.

Liquidity and Capital Management: AG Re’s net cash provided by operating activities was \$79.3 million, reflecting strong core operations. The company paid substantial dividends to its parent, demonstrating excess capital and a disciplined approach to capital management. No new equity was issued, and shareholder equity rose due to retained earnings and other comprehensive income.

Portfolio Quality: The insured portfolio remains largely public finance exposure, representing lower credit risk compared to structured finance. The company’s portfolio is well-diversified by internal rating category and geography, and the bulk of its exposure remains investment grade.

Risk Factors: There is no indication of material adverse developments, loss contingencies, or going concern risks in the auditor’s report. Commitments and contingencies are disclosed as part of normal business operations. No preferred stock is outstanding, and there were no significant changes in accounting policies or audit qualifications.

Shareholder-Relevant and Price-Sensitive Information

  • Earnings Growth: The strong increase in net income and shareholder equity signals robust business performance and may be viewed positively by investors.
  • Dividend Payments: Continued high dividend payouts demonstrate financial strength and a commitment to returning value to shareholders.
  • Stable Portfolio and Conservative Risk Profile: The high proportion of public finance exposure and strong internal ratings reduce the risk of significant credit losses, supporting future earnings stability.
  • No Negative Surprises: The absence of audit qualifications, going concern issues, or large one-off losses increases investor confidence.
  • Potential Share Price Impact: The combination of earnings growth, strong capital position, and ongoing dividends may positively influence the company’s share price, particularly in the context of a stable macro environment for financial guaranty insurers.
  • No Material Adverse Events: There are no disclosures of material adverse events, regulatory actions, or significant litigation in the period under review.

Conclusion

Assured Guaranty Re Ltd.’s 2025 results reinforce its position as a financially robust and conservative financial guaranty provider. Strong earnings, a resilient investment portfolio, stable cash flows, and ongoing dividends position the company well for the future and should be viewed positively by investors.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with professional advisors before making investment decisions. The author and publisher assume no responsibility for actions taken based on the information contained herein.




View ASSURED GUARANTY LTD Historical chart here



SIGA Technologies: TPOXX® (Tecovirimat) Patents, International Sales, and Government Contracts Overview 2025

SIGA Technologies 2025 Annual Report: Key Takeaways for Inve...

Marvell Technology, Inc. Files Form 8-K with SEC – Company Information, Common Stock, and NASDAQ Listing

Marvell Technology, Inc. Files 8-K: Acquisition-Related Shar...

Biogen Inc. Announces Departure of Chief Legal Officer Susan H. Alexander Effective May 2026

Biogen Inc. Announces Departure of Chief Legal Officer Susan...

   Ad